On the other hand, the risk estimated from BCRAT is not dependent on the likelihood of being a BRCA1 or BRCA2 mutation carrier, and the relative risks attributed to family history of breast cancer remain constant with age of the consultee. This evidence concerns the gene BRCA2 and breast cancer.